4//SEC Filing
Bisker-Leib Vered 4
Accession 0001171843-22-001210
CIK 0001738021other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:13 PM ET
Size
5.3 KB
Accession
0001171843-22-001210
Insider Transaction Report
Form 4
Bisker-Leib Vered
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-17+500,000→ 500,000 totalExercise: $2.52Exp: 2032-02-16→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The options vest over 48 substantially equal monthly installments starting 03/17/2022
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001814093
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 7:13 PM ET
- Size
- 5.3 KB